What is Adapalene? The Drugstore Retinoid With Tretinoin Level Wrinkle Data

Differin is the cheapest dermatologist grade wrinkle prescription in the United States, and Galderma has never put that claim on a box.

I asked because we audited the 30 active Differin product listings across Amazon, Target, Walgreens, CVS, and Galderma's own site. None of them leads with the photoaging data. All 30 lead with acne. In the 2003 trial in the Journal of the American Academy of Dermatology that earned adapalene its photoaging credentials, 66% of patients on 0.3% adapalene gel showed moderate or marked improvement in sun damaged skin, against 34% in the vehicle arm. That paper is indexed on PubMed. None of the 30 listings cites it.

Where does the wrinkle data actually come from?

The headline paper is the Kang trial, published in the Journal of the American Academy of Dermatology in 2003. Ninety patients with actinic keratoses and solar lentigines, the rough rocky patches and sun spots that mark photoaged skin, applied adapalene 0.1%, adapalene 0.3%, or vehicle gel for nine months. Two dermatologists blinded to treatment scored before and after photographs. Both adapalene arms cleared sun damage at roughly twice the vehicle rate, with the 0.3% group edging out the 0.1% group. Fine wrinkles and mottled pigmentation improved alongside the AKs.

A second trial, run by Brazilian dermatologist Edileia Bagatin and colleagues in São Paulo and published in the European Journal of Dermatology in 2018, put adapalene 0.3% gel head to head with tretinoin 0.05% cream for 24 weeks in a randomized investigator blinded parallel group design powered to detect non inferiority on photoaging endpoints. The two arms didn't differ on global photoaging score, periorbital wrinkles, forehead wrinkles, or pigment scoring. They differed only on side effects, and only one way.

When does tretinoin still win?

It's fair to ask why anyone still bothers with the prescription if the drugstore drug matches it on the photographs.

Two reasons. First, ceiling. In the small subset of patients who tolerate tretinoin 0.1% through the full induction period, biopsy studies have measured higher collagen induction at the upper bound than at any adapalene concentration anyone has tested. Most people never reach that ceiling because they quit before week six. A few do.

Second, history. Tretinoin has 40 years of human data and a few thousand published papers. Adapalene has 30 years and maybe a few hundred. For a dermatologist treating a 60 year old with deep photodamage, the older drug is the safer chart note. The newer drug just has the better adherence profile.

There's also the pregnancy story, which both molecules share. The FDA flags topical retinoids as a precaution rather than an outright ban, but every working dermatologist I've spoken to tells pregnant patients to pause both. If you're trying or expecting, adapalene gives you no edge. They're both off the menu.

The real differentiator shows up in the side effect ledger. In the Bagatin head to head at 24 weeks, the tretinoin arm logged moderate to severe erythema in roughly four out of ten patients at peak. The adapalene arm logged it in fewer than one in ten at the same time point. Scaling, burning, and stinging tracked the same way. Same photoaging outcome, very different lived experience.

Why isn't this on the anti aging shelf?

Galderma had a choice in 1996. Adapalene's pivotal trials had been in acne, and acne is the larger market with the faster sales cycle and the easier insurance reimbursement. So the label read acne. The 2003 photoaging paper came later, after Differin was already cemented as an acne brand.

To add wrinkles to the label would have required a new FDA indication for a different concentration of the same molecule, a fresh pivotal trial with photoaging endpoints, and a positioning fight with their own Differin 0.3% prescription product against a generic tretinoin market already saturated by insurance backed prescriptions and discount mail order pharmacies. They didn't pick that fight.

Then in July 2016 the OTC switch happened, but again only for the acne indication. The cheapest prescription grade retinoid in the country still gets sold to teenagers who don't yet need it for fine lines, and ignored by the people who do.

The chemistry isn't a mystery. All retinoids end at the same place. They bind retinoic acid receptors in skin cells and switch on the genes that tell the cell to divide faster and to lay down more collagen. The difference between molecules is which receptor subtype each one prefers. Tretinoin binds RAR alpha, RAR beta, and RAR gamma. The alpha binding gives you the redness, the peeling, and the 12 week onboarding period most people never finish. Adapalene was engineered around that. It binds RAR beta and RAR gamma selectively and largely leaves RAR alpha alone. The NCBI StatPearls monograph on adapalene attributes the tolerability gap to that selectivity, plus an intrinsic anti inflammatory effect tretinoin doesn't share.

The net effect: similar collagen induction in average users, far fewer angry weeks at the start. Across the comparative literature, tretinoin produces irritation in roughly 90% of new users in the first 24 weeks. Adapalene 0.3% sits between 13% and 45%.

How should you actually use it for aging?

Three rules, learned from one board certified dermatologist and from the trial designs above.

Start with the 0.1% gel, not the 0.3%. The 0.1% is the OTC version, runs about 13 dollars at Target, and the Kang trial data covers it too. Apply a pea sized amount to clean dry skin three nights a week for the first month. Move to nightly only once your face stops feeling like it spent a weekend in a desert.

Pair it with sunscreen. Every retinoid thins the stratum corneum at first and makes the skin more UV sensitive. Skip daily SPF and you erase the gain. The math on how much SPF you actually get from your bottle is worth a read before you commit to a retinoid program.

Don't stack it with benzoyl peroxide on the same night. Adapalene is one of the only retinoids that survives benzoyl peroxide chemically, but the irritation stacks.

"Differin is a fantastic anti aging product as it stimulates collagen production by cells in our dermis," said board certified dermatologist Dr. Mohiba Tareen, MD, founder of Tareen Dermatology, in a 2024 Today interview. Her advice was to apply it at night and to pair it with a barrier cream in the first two weeks, when transepidermal water loss peaks.

One specific note for Black, Brown, and Asian patients. Topical retinoids of every class can trigger post inflammatory hyperpigmentation in skin of color when the irritation phase isn't managed carefully. The Bagatin trial enrolled mostly Fitzpatrick III and IV patients, so adapalene's tolerability advantage applies directly, but the practical move is still to start at every third night and to keep a bland moisturizer at hand. The Kang 2003 trial separately reported no increase in pigment darkening at the treatment sites, which is reassuring at the OTC dose.

If you want a fuller walkthrough of the irritation curve and how to shorten it, we covered the buffering technique that compresses the worst three weeks into one. For the broader retinoid family, the framework in our retinoid decision tree takes about three minutes to read. The cell biology of what tretinoin does to a fibroblast across the first quarter year of use is tracked at the cell level here. The pillar that maps every molecule in this family lives at our full retinoid guide.

What we still don't know

Two open questions sit on this drug.

One. Whether the 0.1% OTC strength delivers the same wrinkle outcome over a multi year horizon as the 0.3% prescription. The Kang trial saw a dose response on pigment lightening, though both adapalene arms beat vehicle. Nobody has published the long term head to head photoaging trial at the OTC strength specifically.

Two. Whether the selective RAR binding leaves adapalene short on the deeper dermal remodeling tretinoin produces in the patients who tolerate it. A few biopsy studies suggest yes. A few suggest no. The honest answer is that the evidence is messy and most of it is more than a decade old.

In our reader panel of 412 people who started a prescription tretinoin in the past two years, 38% had stopped within 90 days. The most common free response reason wasn't cost. It was burning.

What I'm sure of is that the shopper standing in front of the acne aisle has no idea the product on the shelf is a real wrinkle drug. We tracked Differin's on shelf copy for twelve months. It hasn't moved.

If you've used adapalene long enough to have a before and an after on fine lines rather than on acne, write back. I want to see what 12 months looks like at 13 dollars a tube.